News Headlines Article

Is California’s stem cell program preparing to waste $700,000?
Los Angeles Times

If you’re betting that the California stem cell agency will spurn key recommendations of a blue-ribbon review panel that criticized its leadership and management structures, you might want to double that bet. Several board members showed overt hostility to the panel’s recommendations during a public meeting today.

The governing board of the agency, the California Institute for Regenerative Medicine, formally received the review report at its meeting today in Los Angeles.

The Institute of Medicine, an affiliate of the National Academy of Sciences, was paid $700,000 by CIRM to conduct the yearlong study of the $6-billion state stem cell program.